Company Filing History:
Years Active: 2018-2025
Title: Inventor Ravi K. Pandrapragada: Pioneering Pharmaceutical Innovations
Introduction
Ravi K. Pandrapragada, an accomplished inventor based in Clarksburg, MD, has made significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he is renowned for his innovative approaches to drug formulation. His expertise in the area is reflected in his research and development, particularly in the synthesis of complex compounds.
Latest Patents
Among his latest innovations is the patented process for preparing a batch of highly purified pharmaceutical grade tasimelteon. This process involves analyzing tasimelteon synthesized under Good Manufacturing Practice (GMP) conditions for the presence of identified impurities. This technology ensures that pharmaceutical-grade tasimelteon meets stringent quality standards, which is essential for its application in clinical settings.
Career Highlights
Ravi K. Pandrapragada currently works at Vanda Pharmaceuticals Inc., a company deeply engaged in the development of innovative therapies for underserved patient populations. His role at the company has allowed him to contribute significantly to advancements in pharmaceutical science, particularly in the realm of sleep and mood disorders.
Collaborations
Throughout his career, Ravi has collaborated with various respected professionals in the industry, including notable colleagues such as Deepak Phadke and Natalie M. Platt. These collaborations have facilitated a vibrant exchange of ideas and fostered an environment conducive to groundbreaking research and development.
Conclusion
Ravi K. Pandrapragada's impressive portfolio of patents underscores his dedication to innovation in pharmaceuticals. His work not only enhances the quality of therapeutics but also exemplifies the critical role inventors play in advancing healthcare solutions. As he continues to push the boundaries of pharmaceutical science, his contributions have the potential to improve patient outcomes and enhance therapeutic efficacy across the globe.